Pesquisar
Sophia Genetics SA
SOPHAdicionar à lista de desejos
7.860USD
-0.010-0.13%
Horário de mercado 09/14, 13:56（ET）
669.10MValor de mercado
PerdaP/L TTM
Mais detalhes de Sophia Genetics SA Empresa
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Sophia Genetics SA Perfil
Código da empresaSOPH
Nome da EmpresaSOPHiA GENETICS SA
Data de listagemJul 23, 2021
CEOCamblong (Jurgi)
Número de funcionários423
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 23
EndereçoLa Piece 12
CidadeROLLE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísSwitzerland
Código postalCH-1180
Telefone41216941060
Sitehttps://www.sophiagenetics.com/
Código da empresaSOPH
Data de listagemJul 23, 2021
CEOCamblong (Jurgi)
Executivos da empresa Sophia Genetics SA
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
443.79K
-12.17%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
443.79K
-12.17%
Mr. Troy M. Cox
Mr. Troy M. Cox
Independent Director
Independent Director
294.96K
+6.69%
Mr. Troy M. Cox
Mr. Troy M. Cox
Independent Director
Independent Director
294.96K
+6.69%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Perguntas frequentes
Quem são os cinco principais acionistas de Sophia Genetics SA?
Os cinco principais acionistas de Sophia Genetics SA são: Dr. Jurgi Camblong, Ph.D.
Quantas instituições possuem ações da Sophia Genetics SA (SOPH)?
Em 2026Q1, 89 instituições possuíam ações da Sophia Genetics SA, com valor de mercado aproximado de 27.73M, representando 38.63% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -11894064.00.